Numerous cellular clusters across many solid tumors revealed differential expression of CD320 including stomach adenocarcinoma (STAD), colorectal cancer (CRC), Merkel cell carcinoma (MCC), NSCLC, ICC, and SKCM, among others (Figure 5A). This evidence concerns the gene CD320 and intrahepatic cholangiocarcinoma.